Skip to main content
Erschienen in: Obesity Surgery 10/2008

01.10.2008 | Review

Deciphering the Sleeve: Technique, Indications, Efficacy, and Safety of Sleeve Gastrectomy

verfasst von: Ehab Akkary, Andrew Duffy, Robert Bell

Erschienen in: Obesity Surgery | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

Some institutions perform sleeve gastrectomy (SG) as the initial operation for high-risk, high body mass index patients planning a definitive weight loss operation in 12–18 months. Other institutions consider SG a viable alternative to other bariatric operations. SG is frequently debated among the bariatric surgeons. Many questions remain about the current state of SG. Should it be performed as a definitive weight loss procedure or as a bridge for another bariatric procedure? Is there a specific BMI at which point SG should be encouraged? Is the weight loss comparable to other bariatric procedures? Is there a higher risk of gastric leak? What is the appropriate sleeve size? What are the hormonal benefits? Does SG predispose to gastroesophageal reflux disease? What is the mechanism of weight loss? Are long-term results available? And what are the complications? We conducted an extensive literature review aiming to resolve these commonly asked questions.
Literatur
1.
Zurück zum Zitat Gumbs A, Gagner M, Dakin G, et al. Sleeve gastrectomy for morbid obesity. Obes Surg. 2007;17:962–9.PubMedCrossRef Gumbs A, Gagner M, Dakin G, et al. Sleeve gastrectomy for morbid obesity. Obes Surg. 2007;17:962–9.PubMedCrossRef
2.
Zurück zum Zitat Deitel M, Crosby R, Gagner M. The first international consensus summit for sleeve gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg. 2008;18:487–96.PubMedCrossRef Deitel M, Crosby R, Gagner M. The first international consensus summit for sleeve gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg. 2008;18:487–96.PubMedCrossRef
3.
Zurück zum Zitat Cottam D, Qureshi F, Mattar S, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.PubMedCrossRef Cottam D, Qureshi F, Mattar S, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.PubMedCrossRef
4.
Zurück zum Zitat Hamoui N, Anthone G, Kaufman H, et al. Sleeve gastrectomy in the high-risk patient. Obes Surg. 2006;16:1445–9.PubMedCrossRef Hamoui N, Anthone G, Kaufman H, et al. Sleeve gastrectomy in the high-risk patient. Obes Surg. 2006;16:1445–9.PubMedCrossRef
5.
Zurück zum Zitat Moon Han S, Kim W, Oh J. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469–75.PubMedCrossRef Moon Han S, Kim W, Oh J. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469–75.PubMedCrossRef
6.
Zurück zum Zitat Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16:1138–44.PubMedCrossRef Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16:1138–44.PubMedCrossRef
7.
Zurück zum Zitat Gumbs A, Modlin I, Ballantyne G. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15:462–73.PubMedCrossRef Gumbs A, Modlin I, Ballantyne G. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15:462–73.PubMedCrossRef
8.
Zurück zum Zitat Mongol P, Chosidow D, Marmuse J. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg. 2005;15:1030–3.CrossRef Mongol P, Chosidow D, Marmuse J. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg. 2005;15:1030–3.CrossRef
9.
Zurück zum Zitat Catheline J, Cohen R, Khochtali I, et al. Treatment of super super morbid obesity by sleeve gastrectomy. Presse Med. 2006;35:383–7.PubMedCrossRef Catheline J, Cohen R, Khochtali I, et al. Treatment of super super morbid obesity by sleeve gastrectomy. Presse Med. 2006;35:383–7.PubMedCrossRef
10.
Zurück zum Zitat Langer F, Bohdjalian A, Felberbauer F, et al. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg. 2006;16:166–71.PubMedCrossRef Langer F, Bohdjalian A, Felberbauer F, et al. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg. 2006;16:166–71.PubMedCrossRef
11.
Zurück zum Zitat Zhang W, Mason E, Renquist K, et al. Factors influencing survival following surgical treatment of obesity. Obes Surg. 2005;15:43–50.PubMedCrossRef Zhang W, Mason E, Renquist K, et al. Factors influencing survival following surgical treatment of obesity. Obes Surg. 2005;15:43–50.PubMedCrossRef
12.
Zurück zum Zitat Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. Position statement: sleeve gastrectomy as a bariatric procedure. Surg Obes Rel Dis. 2007;3:573–6.CrossRef Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. Position statement: sleeve gastrectomy as a bariatric procedure. Surg Obes Rel Dis. 2007;3:573–6.CrossRef
13.
Zurück zum Zitat Lee C, Cirangle P, Jossart G. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007;21:1810–6.PubMedCrossRef Lee C, Cirangle P, Jossart G. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007;21:1810–6.PubMedCrossRef
14.
Zurück zum Zitat Melissas J, Koukouraki S, Askoxylakis J, et al. Sleeve gastrectomy: a restrictive procedure? Obes Surg. 2007;17:57–62.PubMedCrossRef Melissas J, Koukouraki S, Askoxylakis J, et al. Sleeve gastrectomy: a restrictive procedure? Obes Surg. 2007;17:57–62.PubMedCrossRef
15.
Zurück zum Zitat Roa P, Kaidar-Person O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16:1323–6.PubMedCrossRef Roa P, Kaidar-Person O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16:1323–6.PubMedCrossRef
16.
Zurück zum Zitat Himpens J, Dapri G, Cadiere G. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–6.PubMedCrossRef Himpens J, Dapri G, Cadiere G. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–6.PubMedCrossRef
17.
Zurück zum Zitat Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super obese patients (BMI > or =50). Obes Surg. 2005;15:612–7.PubMedCrossRef Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super obese patients (BMI > or =50). Obes Surg. 2005;15:612–7.PubMedCrossRef
18.
Zurück zum Zitat Baltasar A, Serra C, Perez N, et al. Laparoscopic sleeve gastrectomy: a multipurpose bariatric operation. Obes Surg. 2005;15:1124–8.PubMedCrossRef Baltasar A, Serra C, Perez N, et al. Laparoscopic sleeve gastrectomy: a multipurpose bariatric operation. Obes Surg. 2005;15:1124–8.PubMedCrossRef
19.
Zurück zum Zitat Langer F, Reza Hoda M, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–9.PubMedCrossRef Langer F, Reza Hoda M, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–9.PubMedCrossRef
20.
Zurück zum Zitat Almogy G, Crookes P, Anthone G. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg. 2004;14(4):492–7.PubMedCrossRef Almogy G, Crookes P, Anthone G. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg. 2004;14(4):492–7.PubMedCrossRef
21.
Zurück zum Zitat Regan J, Inabnet W, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861–4.PubMedCrossRef Regan J, Inabnet W, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861–4.PubMedCrossRef
22.
Zurück zum Zitat Parikh M, Young L, Strain G, et al. Laparoscopic sleeve gastrectomy: does bougie size affect mean %EWL? Short-term outcomes. Surg Obes Relat Dis. 2007;3:353–7 (abstract). Parikh M, Young L, Strain G, et al. Laparoscopic sleeve gastrectomy: does bougie size affect mean %EWL? Short-term outcomes. Surg Obes Relat Dis. 2007;3:353–7 (abstract).
23.
Zurück zum Zitat Lalor PF, Tucker ON, Szomstein S, et al. Complications after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2008;4:33–8.PubMedCrossRef Lalor PF, Tucker ON, Szomstein S, et al. Complications after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2008;4:33–8.PubMedCrossRef
24.
Zurück zum Zitat Givon-Madiala O, Spector R, Wasserberg N, et al. Technical aspect of laparoscopic sleeve gastrectomy in 25 morbidly obese patients. Obes Surg. 2007;17(6):722–7.CrossRef Givon-Madiala O, Spector R, Wasserberg N, et al. Technical aspect of laparoscopic sleeve gastrectomy in 25 morbidly obese patients. Obes Surg. 2007;17(6):722–7.CrossRef
25.
Zurück zum Zitat Sue-Ling D. Surgical management of morbid obesity. 3rd ed. Oxford: Butterworth-Heinemann; 1995. Sue-Ling D. Surgical management of morbid obesity. 3rd ed. Oxford: Butterworth-Heinemann; 1995.
26.
Zurück zum Zitat Johnston D, Dachtler J, Sue-Ling H, et al. The Magenstrasse and Mill operation for morbid obesity. Obes Surg. 2003;13:10–6.PubMedCrossRef Johnston D, Dachtler J, Sue-Ling H, et al. The Magenstrasse and Mill operation for morbid obesity. Obes Surg. 2003;13:10–6.PubMedCrossRef
27.
Zurück zum Zitat Dapri G, Vaz C, Cadiere G, et al. A prospective randomized study comparing two different techniques for laparoscopic sleeve gastrectomy. Obes Surg. 2007;17(11):1435–41PubMedCrossRef Dapri G, Vaz C, Cadiere G, et al. A prospective randomized study comparing two different techniques for laparoscopic sleeve gastrectomy. Obes Surg. 2007;17(11):1435–41PubMedCrossRef
28.
Zurück zum Zitat Lin E, Gletsu N, Fugate K, et al. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg. 2004;139:780–4.PubMedCrossRef Lin E, Gletsu N, Fugate K, et al. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg. 2004;139:780–4.PubMedCrossRef
29.
Zurück zum Zitat Kotidis E, Koliakos G, Baltzopoulos V, et al. Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment–a prospective study. Obes Surg. 2006;16(11):1425–32.PubMedCrossRef Kotidis E, Koliakos G, Baltzopoulos V, et al. Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment–a prospective study. Obes Surg. 2006;16(11):1425–32.PubMedCrossRef
30.
Zurück zum Zitat Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247(3):401–7.PubMedCrossRef Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247(3):401–7.PubMedCrossRef
31.
Zurück zum Zitat Klaus A, Weiss H. Is preoperative manometry in restrictive bariatric procedures necessary? Obes Surg. 2008 Apr 2 (in press). Klaus A, Weiss H. Is preoperative manometry in restrictive bariatric procedures necessary? Obes Surg. 2008 Apr 2 (in press).
32.
Zurück zum Zitat Braghetto I, Korn O, Valladares H, et al. Laparoscopic sleeve gastrectomy: surgical technique, indications and clinical results. Obes Surg. 2007;17:1442–50, Mar 12.PubMedCrossRef Braghetto I, Korn O, Valladares H, et al. Laparoscopic sleeve gastrectomy: surgical technique, indications and clinical results. Obes Surg. 2007;17:1442–50, Mar 12.PubMedCrossRef
33.
Zurück zum Zitat Bergmann JF, Chassany O, Petit A, et al. Correlation between echographic gastric emptying and appetite: influence of psyllium. Gut. 1992;33(8):1042–3.PubMedCrossRef Bergmann JF, Chassany O, Petit A, et al. Correlation between echographic gastric emptying and appetite: influence of psyllium. Gut. 1992;33(8):1042–3.PubMedCrossRef
Metadaten
Titel
Deciphering the Sleeve: Technique, Indications, Efficacy, and Safety of Sleeve Gastrectomy
verfasst von
Ehab Akkary
Andrew Duffy
Robert Bell
Publikationsdatum
01.10.2008
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 10/2008
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9551-6

Weitere Artikel der Ausgabe 10/2008

Obesity Surgery 10/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.